Product Information
METHOCARBAMOL 750 MG TABLET is a generic product labeled by Oxford Pharmaceuticals, LLC, priced at $0.0431 per EA under NDC 69584061250. Its NADAC has been published 370 times since Sep 4, 2019.
FDA first approved this application on Jan 29, 2003. Its Orange Book therapeutic-equivalence code is AA.
Strength
750 mg/1
Manufacturer
Oxford Pharmaceuticals, LLCNDC
69584061250
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHOCARBAMOLApproval Type
Generic (ANDA)
FDA Application
ANDA040489FDA Approved
1/29/2003
TE Code
AA
On Market Since
8/15/2019
Pharmacological Classes
Price Statistics
The NADAC for METHOCARBAMOL 750 MG TABLET has been published 370 times since Sep 4, 2019, and over the history we have for it it has declined 60.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0431 per EA |
|---|---|
| All-time high | $0.1174 (Oct 16, 2019) |
| All-time low | $0.0346 (Jul 17, 2024) |
| 52-week high | $0.0438 |
| 52-week low | $0.0423 |
| Median price | $0.0501 |
| Average price | $0.0652 |
| Largest weekly change | +34.4% (Aug 21, 2024) |
| Weeks tracked | 370 |
| Tracking since | Sep 4, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oxford Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methocarbamol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHOCARBAMOL 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHOCARBAMOL 750 MG TABLET, manufactured by Oxford Pharmaceuticals, LLC, is $0.0431 per EA (NDC 69584061250), effective Sep 30, 2026.
How has the price of METHOCARBAMOL 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHOCARBAMOL 750 MG TABLET has declined 60.6%. It has been tracked across 370 weekly CMS publications since Sep 4, 2019.
What are the highest and lowest recorded NADAC prices for METHOCARBAMOL 750 MG TABLET?
Since Sep 4, 2019, the NADAC for METHOCARBAMOL 750 MG TABLET has ranged from a low of $0.0346 (Jul 17, 2024) to a high of $0.1174 (Oct 16, 2019), with a median of $0.0501 per EA.
Are there cheaper alternatives to METHOCARBAMOL 750 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHOCARBAMOL 750 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHOCARBAMOL 750 MG TABLET?
METHOCARBAMOL 750 MG TABLET (NDC 69584061250) is labeled by Oxford Pharmaceuticals, LLC, and CMS classifies it as a generic product.